2003
DOI: 10.1161/01.cir.0000053730.47739.3c
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

49
1,515
10
77

Year Published

2003
2003
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 2,179 publications
(1,651 citation statements)
references
References 53 publications
49
1,515
10
77
Order By: Relevance
“…[25][26][27] Inflamation in acute coronary syndromes is suggested by numerous clinical studies showing increased acute-phase reactants in the serum of patients with unstable angina and those at risk of future myocardial infarction. 28,29 In the present study, the preinterventional peak monocyte count was significantly higher in the ISR group and the reintervention group than in that with no ISR and with no reintervention. Furthermore, significant positive correlations were found between preinterventional peak monocyte count and plaque, media CSA, and plaque burden, and between preinterventional peak monocyte count and follow-up neointima area.…”
Section: Discussionsupporting
confidence: 41%
“…[25][26][27] Inflamation in acute coronary syndromes is suggested by numerous clinical studies showing increased acute-phase reactants in the serum of patients with unstable angina and those at risk of future myocardial infarction. 28,29 In the present study, the preinterventional peak monocyte count was significantly higher in the ISR group and the reintervention group than in that with no ISR and with no reintervention. Furthermore, significant positive correlations were found between preinterventional peak monocyte count and plaque, media CSA, and plaque burden, and between preinterventional peak monocyte count and follow-up neointima area.…”
Section: Discussionsupporting
confidence: 41%
“…CRP levels in blood are a good indicator of the likelihood of acute coronary and cerebral events in both healthy subjects and patients with coronary artery disease. 16,36 CRP is positively associated with BMI and we and others have shown that energy striction and weight loss lowers CRP. 16,37,38 Ziccardi et al 7 found reductions in IL-6, VCAM-1 and ICAM-1 following weight loss of 10 kg however we demonstrated reductions in the ICAM-1 but not VCAM or IL-6.…”
Section: Discussionmentioning
confidence: 74%
“…However, it has been reported that in most clinical settings, a single CRP assessment is likely to be adequate as long as levels of less than 10 mg/l are observed. 22 Although there are many published papers showing that CRP is a potent risk factor for clinical cardiovascular disease, there is scarcity of clinical data regarding the potential aetiological link between CRP and cardiovascular complications. The associations that we observed between measures of arterial stiffness and CRP add to the evidence that there is a relation between subclinical inflammation and functional alteration of large arterial bed and preclinical arterial remodeling (a true prequel to cardiovascular events).…”
Section: Discussionmentioning
confidence: 99%